These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 16421425

  • 1. Thromboembolism in hospitalized neutropenic cancer patients.
    Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.
    J Clin Oncol; 2006 Jan 20; 24(3):484-90. PubMed ID: 16421425
    [Abstract] [Full Text] [Related]

  • 2. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
    Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH.
    Cancer; 2007 Nov 15; 110(10):2339-46. PubMed ID: 17918266
    [Abstract] [Full Text] [Related]

  • 3. Incidence and risk factors of venous thromboembolic events in lymphoma.
    Zhou X, Teegala S, Huen A, Ji Y, Fayad L, Hagemeister FB, Gladish G, Vadhan-Raj S.
    Am J Med; 2010 Oct 15; 123(10):935-41. PubMed ID: 20920696
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
    Kolomansky A, Hoffman R, Sarig G, Brenner B, Haim N.
    Isr Med Assoc J; 2006 Dec 15; 8(12):848-52. PubMed ID: 17214102
    [Abstract] [Full Text] [Related]

  • 5. Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
    Weycker D, Malin J, Kim J, Barron R, Edelsberg J, Kartashov A, Oster G.
    Clin Ther; 2009 May 15; 31(5):1069-81. PubMed ID: 19539108
    [Abstract] [Full Text] [Related]

  • 6. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH.
    J Clin Oncol; 2006 Mar 01; 24(7):1112-8. PubMed ID: 16505431
    [Abstract] [Full Text] [Related]

  • 7. Incidence of venous thromboembolism in patients hospitalized with cancer.
    Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE.
    Am J Med; 2006 Jan 01; 119(1):60-8. PubMed ID: 16431186
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for venous thromboembolism in children.
    Gerotziafas GT.
    Int Angiol; 2004 Sep 01; 23(3):195-205. PubMed ID: 15765033
    [Abstract] [Full Text] [Related]

  • 9. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
    Lin J, Proctor MC, Varma M, Greenfield LJ, Upchurch GR, Henke PK.
    J Vasc Surg; 2003 May 01; 37(5):976-83. PubMed ID: 12756342
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA, Francis CW, Culakova E, Lyman GH.
    Cancer; 2005 Dec 15; 104(12):2822-9. PubMed ID: 16284987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Frequency of venous thromboembolism among hospitalized patients with cancer].
    Conte G, Figueroa G.
    Rev Med Chil; 2008 Dec 15; 136(12):1528-34. PubMed ID: 19350169
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
    Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A, Khan A, Armstrong A, Chan AK.
    Pediatr Blood Cancer; 2008 Dec 15; 51(6):792-7. PubMed ID: 18798556
    [Abstract] [Full Text] [Related]

  • 14. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.
    Ziegler S, Sperr WR, Knöbl P, Lehr S, Weltermann A, Jäger U, Valent P, Lechner K.
    Thromb Res; 2005 Dec 15; 115(1-2):59-64. PubMed ID: 15567454
    [Abstract] [Full Text] [Related]

  • 15. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne M, Culakova E, Poniewierski MS, Wolff D, Dale DC, Crawford J, Lyman GH.
    Cancer; 2007 Oct 01; 110(7):1611-20. PubMed ID: 17705197
    [Abstract] [Full Text] [Related]

  • 16. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.
    Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH.
    Cancer; 2006 May 15; 106(10):2258-66. PubMed ID: 16575919
    [Abstract] [Full Text] [Related]

  • 17. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, Glezer S, Thabane L, Sebaldt RJ, CURVE study investigators.
    Thromb Res; 2007 May 15; 119(2):145-55. PubMed ID: 16516275
    [Abstract] [Full Text] [Related]

  • 18. Length of stay and mortality associated with febrile neutropenia among children with cancer.
    Basu SK, Fernandez ID, Fisher SG, Asselin BL, Lyman GH.
    J Clin Oncol; 2005 Nov 01; 23(31):7958-66. PubMed ID: 16258096
    [Abstract] [Full Text] [Related]

  • 19. Risk factors associated with venous thromboembolic events in patients with malignancy.
    Lin J, Wakefield TW, Henke PK.
    Blood Coagul Fibrinolysis; 2006 Jun 01; 17(4):265-70. PubMed ID: 16651868
    [Abstract] [Full Text] [Related]

  • 20. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party.
    Haematologica; 2008 Mar 01; 93(3):372-80. PubMed ID: 18268279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.